MARTIN NGUYEN: Open Payments
NPI 1396330825 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 24 payments from 10 companies in 2025. Trend: 2023 $494 · 2024 $666 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $113 |
| Exact Sciences Corporation | 6 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 2 | $32 |
| Agios Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| SANOFI PASTEUR INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Sonex Health, Inc. | 1 | $17 |
Products named: JARDIANCE, Cologuard Collection Kit, AIRSUPRA, ELIQUIS, PYRUKYND, Ozempic, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
